ClarvenAI turns filings, earnings, news, peer data, and valuation signals into plain-English stock research — so you can understand the bull case, bear case, valuation setup, and key risks in minutes.
Built for U.S. and Canadian equities today — backed by high-quality paid market data. International stock analysis is on the roadmap.
Plans starting from $6.99/month · North American stocks · Analyst-style research in minutes
ClarvenAI provides research and analysis tools only. It is not personalized investment advice. Valuation estimates are based on available data and assumptions.
Before buying or holding a stock, most investors check prices on one site, analyst targets on another, read news somewhere else, skim filings, and try to piece together whether the stock is expensive or cheap. ClarvenAI brings all of that context into one plain-English stock report — valuation, peers, bull/bear cases, risks, and what to watch — updated daily.
Before buying or selling a stock, spend five minutes reviewing the valuation estimate, peer benchmarks, risks, catalysts, and recent developments. Become an informed investor — understand the long-term reasons to buy or hold a stock, not just what's trending. One better-informed decision could be worth far more than the monthly cost.
For informational purposes only. Not personalized investment advice.
Sample plain-English investment research on U.S. equities — valuation estimate context, peer benchmarks, and bull/bear cases. No login required.
AI demand remains strong, but export restrictions and valuation risk are the key watch items.
View full analysis →Ad growth and AI efficiency support the bull case, while regulation and capex remain the key risks.
View full analysis →Apple’s premium multiple depends on services growth and AI momentum offsetting slower hardware demand.
View full analysis →Tesla’s valuation depends on margin recovery, delivery growth, and investor confidence in autonomy.
View full analysis →Our proprietary algorithm continuously tracks stock prices, news, financial releases, filings, and earnings to generate a signal score and actionable intelligence for every stock we cover.
Estimated valuation ranges based on multiples, peer comparisons, growth, margins, and risk context — for informational purposes only.
Compare companies against relevant peers across growth, profitability, valuation, margins, and business quality.
Turn earnings calls, SEC filings, news, and market moves into plain-English takeaways.
Review the bull case, bear case, valuation risk factors, catalysts, and what to watch next as research context before making your own decision.
ClarvenAI tracks the North American stocks you care about and flags important changes across price moves, news, filings, earnings, valuation, and peer signals.
Product preview
Valuation estimates, peer benchmarking, opportunity scoring, and plain-English research — decision support for better-informed buy, hold, and sell decisions.
Plain-English bull/bear cases, valuation context, risks, filings, earnings, news, and what could change the story.
A 0–100 signal score across valuation, growth, risk, sentiment, and peer-implied upside.
Scan 330+ North American stocks ranked by signal strength, valuation setup, and peer-implied upside.
AI-powered ETF analysis with holdings signals, sector breakdowns, and performance vs S&P 500.
Compare growth, margins, Rule of 40, EV/Revenue, and EV/EBITDA against real public peers.
U.S. and Canadian market briefings with cross-asset signals, plain-English takeaways, and audio narration.
A daily 5:30 PM ET email showing what moved your stocks and why.
See whether moves were driven by earnings, filings, news, or macro — with plain-English summaries of 10-Ks, 10-Qs, and 8-Ks.
See what your entry price assumes about valuation, growth, margins, and risk — before or after you make a decision.
Explore valuation estimates, peer benchmarking, and plain-English investment research on North American stocks.

Find bullish, neutral, and bearish stock signals across hundreds of companies.
Analyst-style evaluation for U.S. and Canadian equities — distilled into steps any investor can follow.
Track the North American stocks you own, follow, or want to research across U.S. and Canadian markets.
Relevant filings, earnings, news, financials, peer data, and market inputs are reviewed for drivers, risks, valuation, and catalysts.
Every day at 5:30 PM ET, see what moved, why it moved, what changed, and what to watch next. Plus get a watchlist email showing your stocks' movements with data-backed explanations.
Get deep stock insights, valuation estimates, peer analysis, watchlist alerts, and daily market intelligence for less than the cost of a few coffees. A 5-minute read before buying or selling could help you make a better-informed decision.
Start freeFor informational purposes only. Not personalized investment advice.
Generic AI waits for you to ask the right question. ClarvenAI monitors your North American watchlist automatically and turns filings, earnings, news, financials, and market data into structured ticker intelligence — per stock, every day, without manual prompts.
| Generic AI | ClarvenAI | |
|---|---|---|
| Monitoring | Manual prompts | Always-on watchlist |
| Source data | Public web | Filings, earnings, news, financials |
| Output | Chat answers | Structured per-ticker intelligence |
| Depth | Surface-level | Bull/bear cases, peer valuation, signals |
| Markets | Generic web data | North American stocks (U.S. + Canada) |
| Research inputs | User-provided context | Structured financial data, filings, earnings, news, and peer data |
30 days free. No credit card required.
Deep stock intelligence for North American equities — valuation estimates, peer analysis, watchlist alerts, and daily market research. Understand what you own before you buy, hold, or sell.
Plans starting from $6.99/month — deep research for less than the cost of a few coffees.
Early pricing available for a limited time.
ClarvenAI is for informational and research purposes only and does not provide personalized investment advice. You are responsible for your own investment decisions.
$10
$6.99/month
Limited time pricing
Track up to 15 North American stocks
$15
$9.99/month
Limited time pricing
Track up to 50 North American stocks with Pro chat access
Quick answers before you start your free trial.
Sign up for a free 30-day trial — no credit card required. You get full access to all features during the trial. After 30 days, choose the Investor or Pro plan to continue.
Watchlist emails are sent daily at 5:30 PM ET after market close, only when meaningful activity is detected in your watchlist. You can also choose weekly emails or turn off emails entirely in Settings.
Typically price moves of ~1%+ paired with credible drivers — earnings, major news, or SEC filings. Every news article is scored 1–5 for market impact. We surface the ones that actually matter.
The Opportunity Score is a 0–100 signal that combines fundamentals, valuation, earnings momentum, peer comparison, sentiment, and price trends. It is not a buy/sell recommendation — it helps you compare signal strength across your watchlist at a glance.
Yes — the daily US and Canadian business brief includes audio narration you can listen to directly in the app. Company intelligence summaries also include an audio version.
AI summaries are generated from real source material — earnings transcripts, SEC filings, and curated news. The AI synthesizes this content; it does not fabricate financial data. Always verify key figures against primary sources. ClarvenAI is an intelligence tool, not a replacement for your own research.
Yes — ClarvenAI covers U.S. and Canadian equities today. Track TSX names alongside U.S. listings with a dedicated Canadian news feed. International stock analysis is on the roadmap.
Free trial: full access for 30 days. Investor plan ($6.99/month): up to 15 North American stocks. Pro plan ($9.99/month): up to 50 stocks. You can upgrade or downgrade anytime.
No — your broker handles trades and account management. ClarvenAI is the intelligence layer on top: plain-English context on what changed, why it matters, and what to watch next.
No. ClarvenAI helps you understand the business, valuation, risks, catalysts, and peer context behind a stock. It does not tell you what to buy or sell. All investment decisions are yours.
ClarvenAI is a research and education tool. It does not provide personalized investment advice, price targets, or buy/sell recommendations.
Generic AI waits for you to ask the right question. ClarvenAI monitors your North American watchlist automatically and turns filings, earnings, news, financials, and market data into structured stock intelligence — without you rewriting prompts every day.
ClarvenAI uses an analyst-style research process powered by AI and structured market data. It reviews filings, earnings, financials, news, peer comparisons, and market signals, then turns them into plain-English stock intelligence. It is not a registered investment adviser and does not provide personalized investment advice.